Cardinal Health, Inc. Overview
Pro stress-test →Cardinal Health reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the prior year. The company is a leading healthcare distributor and services provider operating across pharmaceutical distribution, medical products, and specialty healthcare solutions. Cardinal Health emphasizes double-digit profit expansion across all operating segments and is strengthening its core distribution business while aggressively expanding in higher-margin areas such as specialty and other growth businesses.
Strategic Profile
Pro stress-test →Cardinal Health expects Specialty revenues to exceed $50 billion in fiscal 2026, representing a 16% three-year compound annual growth rate. The completion of the Solaris Health acquisition, major digital platform wins in biopharma, and continued logistics innovation each contributed to market momentum and expansion opportunities. The company's competitive advantage lies in its integrated platform combining core distribution with high-margin specialty and managed services organizations (MSOs).
Competitive Landscape
Pro stress-test →Cardinal Health's price-to-sales multiple rose to 0.22x, surpassing Cencora's, reflecting improved growth momentum and market confidence in sustainable long-term performance. The company competes with major pharmaceutical distributors including Cencora (formerly AmerisourceBergen) and McKesson. Cardinal Health differentiates through specialty pharma, MSO platforms, and direct-to-patient solutions.
Industry Context
Cardinal Health, Inc. operates in Healthcare Distribution and Pharmaceutical Services.
Key facts
Headquarters: Dublin, Ohio · Revenue: $65.6B (Q2 FY2026)